Professor Alessandro Lugli from the Institute of Tissue Medicine and Pathology in Bern has been a wonderful collaborator over the years, together we are improving the morphological diagnosis of colorectal cancer.

ODYSSEY is lead by professor Inti Zlobec with whom we have worked together for a long term, resulting in multiple collaborative grants and papers, as well as scientific exchange programs.

At the Department of Public Health at Erasmus MC Rotterdam professor Iris Lansdorp-Vogelaar and her team work on the evaluation of population screening programs. Together we make sure that the Dutch program is optimised.

Professor Fátima Carneiro is one of the world’s leading experts on (hereditary diffuse) gastric cancer. For years we are working together towards a better understanding of this disease and a better outcome for our patients.

The Gastrointestinal Oncology department (Diagnostics and Treatment Center) of the Netherlands Cancer Institute is one of the centers we collaborate with on the diagnosis and treatment of hereditary diffuse gastric cancer as well as on the serrated pathway of carcinogenesis.

Professor Gina Brown is professor of Gastrointestinal Cancer Imaging at Imperial College London. Together we work on the understanding of tumor response and tumor deposits.

With the research group of Translational Cancer Pathology (Edwards Lab) we received a grant from the Radboud- Glasgow collaboration fund to explore the biology behind signet ring cell carcinoma. While it took a while to meet in person due to COVID19 we firmly established our collaboration, also with education and student exchanges.

Together with the Jamieson spatial lab, lead by Nigel Jamieson at Glasgow University, we took our first step in spatial transcriptomics, figuring out the biology behind tumor deposits and pseudobuds!

Together with Professor Evelien Dekker, CRC Research Amsterdam, we study cancer progression through the serrated pathway as well as monitoring the Dutch population based screening program.

The Dutch nationwide pathology databank Palga is a unique infrastructure that allows us to perform multicenter studies investigating carefully selected series of tissue samples or databases, supported by Palga’s scientific advisors.

Together with Dr. Peter Vermeulen from the Translational Cancer Research Unit from the Oncologic Center Antwerp, we study the morphology of liver metastases. We achieved the implementation of morphologic classification of colorectal liver metastases in international guidelines.

The Catharina Cancer institute in Eindhoven is a large tertiary hospital in the Netherlands. We have a longstanding collaboration with the department of Surgery, initially on locally advanced rectal cancer (professor Harm Rutten) and more recently on appendiceal cancer (professor Ignace de Hingh).

The foundation for hereditary cancers in the Netherlands, StOET, headed by professor Monique van Leerdam, is one of the partners for our research projects.

The Dutch Cancer Society is the main funder of cancer research in the Netherlands. We are very grateful for their continuing support.

The MDL fonds is an independent funding organisation focussed on gastrointestinal diseases. We are happy to work with them towards a healthy gastrointestinal tract.

Horizon Europe is the EU’s key funding programme for research and innovation.

The Hanarth fonds is aimed on stimulating the use of artificial intelligence and machine learning to improve diagnoses, treatment and ultimately outcome of cancer patients. They have supported us in our studies into gallbladder cancer, cancer of unknown primary and hereditary diffuse gastric cancer, for which we are very grateful.

The Dutch Research Council (NWO) is one of the most important science funding bodies in the Netherlands and realises quality and innovation in science, focussed on curiosity-driven research, research related to societal challenges and research infrastructure.

The Radboud Oncologie Fonds is our institutional foundation, that builds a bridge between patients and cancer research. This foundation initiates and supports funding activities and coordinates patient’s driven research projects.